Detection and analysis of hepatitis C virus in HIV-infected patients in the Guangxi province of China

Wu,Shu‑Zhi; Wei,Jin‑Lu; Xu,Bin; Wei,Peng‑Hai; Yang,Yan; Qin,Bin; Xie,Zhi‑Chun

doi:10.3892/etm.2017.4067

Detection and analysis of hepatitis C virus in HIV-infected patients in the Guangxi province of China

Authors:
- Shu‑Zhi Wu
- Jin‑Lu Wei
- Bin Xu
- Peng‑Hai Wei
- Yan Yang
- Bin Qin
- Zhi‑Chun Xie
View Affiliations

Affiliations: Department of Epidemiology, Public Health School, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China
Published online on: January 20, 2017 https://doi.org/10.3892/etm.2017.4067
Pages: 917-923
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the prevalence rate of hepatitis C virus (HCV) infection in human immunodeficiency virus (HIV)‑positive individuals and to study the infection status of HCV RNA in HIV‑infected individuals who did not have anti‑HCV antibodies in the Guangxi province of China, in order to provide basis for screening and clinical treatment of hepatitis C in future. Data were collected from patients recruited via a questionnaire. Between August 2008 and January 2009, 300 HIV‑infected individuals were randomly selected from various HIV monitoring points in Liuzhou and Qinzhou (Guangxi, China). In addition, 41 patients with only hepatitis C were recruited from a hospital clinic (First Affiliated Hospital of Guangxi Medical University, Nanning, China). HCV antibodies in patient serum samples were detected by ELISA. HCV RNA expression was detected using nested polymerase chain reaction (PCR), HCV RNA levels in the serum were evaluated using quantitative fluorescence PCR, and HCV genotypes were confirmed using restriction fragment length polymorphism. The infection rate of HCV in the HIV‑infected people was 48.67%. The anti‑HCV positive rate differed between routes of disease transmission: Anti‑HCV positive rate was 63.7% among drug users, 34.96% among sex‑transmitted persons and 1.37% among other persons. In the anti‑HCV‑negative group, the HCV RNA‑positive rate was 26.62%. In the anti‑HCV‑positive group, HCV RNA positive rate was 78.08%. HCV RNA level of HIV/HCV coinfected patients was higher than those infected with HCV alone, and there was no difference of anti-HCV-positive rate among different levels of HCV RNA. HCV genotypes of HIV/HCV coinfected persons showed diversity across Guangxi, and the predominant ones were the 1b and mixed subtypes. The predominant HCV genotypes were 6a, mixed subtypes and 3b amongst patients that contracted HCV via drug use‑related routes of transmission. The patients with HCV transmission routes other than drug‑related routes possessed 1b and 1a+1b genotypes. In conclusion, there was a large proportion of HIV infected persons with mixed HCV infection in the Guangxi province of China. The present results show that 26.62% of HCV‑infected persons will be fail to be diagnosed with hepatitis C virus coinfection if we simply use ELISA to detect HCV antibody. The predominant HCV genotypes were 1b, mixed, 6a and 3b in HIV/HCV coinfected persons.

View Figures

View References

1	Semba RD, Kumwenda N, Hoover DR, Taha TE, Quinn TC, Mtimavalye L, Biggar RJ, Broadhead R, Miotti PG, Sokoll LJ, et al: Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 180:93–98. 1999. View Article : Google Scholar : PubMed/NCBI
2	Attia S, Egger M, Müller M, Zwahlen M and Low N: Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis. AIDS. 23:1397–1404. 2009. View Article : Google Scholar : PubMed/NCBI
3	Macías J, Palacios RB, Claro E, Vargas J, Vergara S, Mira JA, Merchante N, Corzo JE and Pineda JA: High prevalence of hepatitis C virus infection among noninjecting drug users: Association with sharing the inhalation implements of crack. Liver Int. 28:781–786. 2008. View Article : Google Scholar : PubMed/NCBI
4	Sulkowski MS, Mast EE, Seeff LB and Thomas DL: Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis. 30:(Suppl 1). S77–S84. 2000. View Article : Google Scholar : PubMed/NCBI
5	Soriano V, Vispo E, Labarga P, Medrano J and Barreiro P: Viral hepatitis and HIV co-infection. Antiviral Res. 85:303–315. 2010. View Article : Google Scholar : PubMed/NCBI
6	de Lédinghen V, Barreiro P, Foucher J, Labarga P, Castéra L, Vispo ME, Bernard PH, Martin-Carbonero L, Neau D, García-Gascó P, et al: Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy. J Viral Hepat. 15:427–433. 2008. View Article : Google Scholar : PubMed/NCBI
7	Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures. J Viral Hepat. 11:97–107. 2004. View Article : Google Scholar : PubMed/NCBI
8	Cockerham L, Scherzer R, Zolopa A, Rimland D, Lewis CE, Bacchetti P, Grunfeld C, Shlipak M and Tien PC: Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era. J Acquir Immune Defic Syndr. 53:102–106. 2010. View Article : Google Scholar : PubMed/NCBI
9	Hernandez MD and Sherman KE: HIV/hepatitis C coinfection natural history and disease progression. Curr Opin HIV AIDS. 6:478–482. 2011. View Article : Google Scholar : PubMed/NCBI
10	Li L, Bao ZY, Sui HS, Liu SY, Zhuang DM, Liu YJ, Miao WQ, Li Z and Li JY: Investigation on HCV co-infection in HIV-infected people in some areas of China. Zhongguo Ai Zi Bing Xing Bing. 14:9–11. 2008.(In Chinese).
11	Yin N, Mei S and Zhang LQ: Outbreak of HIV and HCV co-infection among intravenous drug users and illegal blood donors in China. Zhongguo Kang Gan Ran Hua Liao Za Zhi. 2:67–69. 2002.(In Chinese).
12	Ma JX, Wang JR, Shen YZ, Zhang RF, Liu XN, Jiang XY, Sun HQ and Lu HZ: Clinical epidemiology studies on HIV-1/AIDS subjects co-infected with HBV and/or HCV in Shanghai. Wei Sheng Wu Yu Gan Ran. 1:207–210. 2006.(In Chinese).
13	Xia YH, McLaughlin MM, Chen W, Ling L and Tucker JD: HIV and hepatitis C virus testing delays at methadone clinics in Guangdong Province, China. PLoS One. 8:e667872013. View Article : Google Scholar : PubMed/NCBI
14	Xia YH, Chen W, Tucker JD, Wang C and Ling L: HIV and hepatitis C virus test uptake at methadone clinics in Southern China: Opportunities for expanding detection of bloodborne infections. BMC Public Health. 13:8992013. View Article : Google Scholar : PubMed/NCBI
15	Caliendo AM, Gilbert DN, Ginocchio CC, Hanson KE, May L, Quinn TC, Tenover FC, Alland D, Blaschke AJ, Bonomo RA, et al: Infectious Diseases Society of America (IDSA): Better tests, better care: Improved diagnostics for infectious diseases. Clin Infect Dis. 57:(Suppl 3). S139–S170. 2013. View Article : Google Scholar : PubMed/NCBI
16	Su Q, Liang H, Cen P, Bi Z and Zhou P: HIV type 1 subtypes based on the pol gene and drug resistance mutations among antiretroviral-naive patients from Guangxi, Southern China. AIDS Res Hum Retroviruses. 28:725–728. 2012. View Article : Google Scholar : PubMed/NCBI
17	Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ and Henderson BE: Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 49:2506–2509. 1989.PubMed/NCBI
18	Tian D, Li L, Liu Y, Li H, Xu X and Li JD: Different HCV genotype distributions of HIV-infected individuals in Henan and Guangxi, China. PLoS One. 7:e503432012. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Sanger F, Nicklen S and Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 74:5463–5467. 1977. View Article : Google Scholar : PubMed/NCBI
21	Chinchai T, Labout J, Noppornpanth S, Theamboonlers A, Haagmans BL, Osterhaus AD and Poovorawan Y: Comparative study of different methods to genotype hepatitis C virus type 6 variants. J Virol Methods. 109:195–201. 2003. View Article : Google Scholar : PubMed/NCBI
22	Moreira S, Garcia RF, Gutberlet A, Bertol BC, Ferreira LE, Mde S Pinho and de França PH: A straightforward genotyping of the relevant IL28B SNPs for the prediction of hepatitis C treatment outcome. J Virol Methods. 184:93–97. 2012. View Article : Google Scholar : PubMed/NCBI
23	Fattovich G, Stroffolini T, Zagni I and Donato F: Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 27:(Suppl 1). S35–S50. 2004. View Article : Google Scholar
24	Moradpour D and Blum HE: Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 17:477–483. 2005. View Article : Google Scholar : PubMed/NCBI
25	Williams R: Global challenges in liver disease. Hepatology. 44:521–526. 2006. View Article : Google Scholar : PubMed/NCBI
26	Taye S and Lakew M: Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia. BMC Immunol. 17:14–23. 2013.
27	Bouare N, Gothot A, Delwaide J, Bontems S, Vaira D, Seidel L, Gerard P and Gerard C: Epidemiological profiles of human immunodeficiency virus and hepatitis C virus infections in Malian women: Risk factors and relevance of disparities. World J Hepatol. 5:196–205. 2013.PubMed/NCBI
28	Merchante N, Girón-González JA, González-Serrano M, Torre-Cisneros J, García-García JA, Arizcorreta A, Ruiz-Morales J, Cano-Lliteras P, Lozano F, Martínez-Sierra C, et al: Grupo Andaluz para el Estudio de las Enfermedades Infecciosas: Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS. 20:49–57. 2006. View Article : Google Scholar : PubMed/NCBI
29	García-Samaniego J, Rodríguez M, Berenguer J, Rodríguez-Rosado R, Carbó J, Asensi V and Soriano V: Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol. 96:179–183. 2001. View Article : Google Scholar : PubMed/NCBI
30	Hadush H, Gebre-Selassie S and Mihret A: Hepatitis C virus and human immunodeficiency virus coinfection among attendants of voluntary counseling and testing centre and HIV follow up clinics in Mekelle Hospital. Pan Afr Med J. 14:1072013. View Article : Google Scholar : PubMed/NCBI
31	Chang KM, Thimme R, Melpolder JJ, Oldach D, Pemberton J, Moorhead-Loudis J, McHutchison JG, Alter HJ and Chisari FV: Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology. 33:267–276. 2001. View Article : Google Scholar : PubMed/NCBI
32	Riestra S, Fernández E, Rodríguez M and Rodrigo L: Hepatitis C virus infection in heterosexual partners of HCV carriers. J Hepatol. 22:509–510. 1995. View Article : Google Scholar : PubMed/NCBI
33	Sherman KE, Shire NJ, Rouster SD, Peters MG, Koziel M James, Chung RT and Horn PS: Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology. 128:313–327. 2005. View Article : Google Scholar : PubMed/NCBI
34	Briat A, Dulioust E, Galimand J, Fontaine H, Chaix ML, Letur-Könirsch H, Pol S, Jouannet P, Rouzioux C and Leruez-Ville M: Hepatitis C virus in the semen of men coinfected with HIV-1: Prevalence and origin. AIDS. 19:1827–1835. 2005. View Article : Google Scholar : PubMed/NCBI
35	Taylor LE, Swan T and Mayer KH: HIV coinfection with hepatitis C virus: Evolving epidemiology and treatment paradigms. Clin Infect Dis. 55:(Suppl 1). S33–S42. 2012. View Article : Google Scholar : PubMed/NCBI
36	Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, Lundgren JD and Kirk O: EuroSIDA Study Group: The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe-a review of published results. Cent Eur J Public Health. 16:99–105. 2008.PubMed/NCBI
37	Liu Z, Jiang Y, Wu Hao, Xiao Y, Zhang YH, Pan PL and Xiang Z: Mutual effect of HIV/HCV Co-infection on laboratory diagnosis. Chin J Lab Med. 28:691–693. 2005.
38	Mboto CI, Fielder M, Davies-Russell A and Jewell AP: Prevalence of HIV-1, HIV-2, hepatitis C and co-infection in the gambia. West Afr J Med. 28:16–19. 2009.PubMed/NCBI
39	Onakewhor JU and Okonofua FE: The prevalence of dual human immunodeficiency virus/hepatitis C virus (HIV/HCV) infection in asymptomatic pregnant women in Benin City, Nigeria. Afr J Reprod Health. 13:97–108. 2009.PubMed/NCBI
40	Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA and Dore GJ: HIV and hepatitis C coinfection within the CAESAR study. HIV Med. 5:174–179. 2004. View Article : Google Scholar : PubMed/NCBI
41	Walusansa V and Kagimu M: Screening for hepatitis C among HIV positive patients at Mulago hospital in Uganda. Afr Health Sci. 9:143–146. 2009.PubMed/NCBI
42	Chinese Society of Hepatology, . Chinese Society of Infectious Diseases and Parasitic Diseases. Principles for prevention and treatment of hepatitis C. Chin J Int Med (Chin). 43:551–555. 2004.